Plain-English translation of NCT06155708 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether exogenous ketone monoester — a drinkable supplement containing ketones — can help improve heart health in women with PCOS. PCOS affects many women and increases the risk of heart disease, so researchers want to see if this supplement can help control blood sugar, improve blood vessel function, and lower blood pressure.
Women with PCOS have a higher risk of heart disease, but there aren't many proven treatments to specifically help their heart health. Early research suggests this medication may help with the main heart-related problems that come with PCOS, so doctors want to test whether it actually works in people with this condition.
You likely qualify if…
You likely don't qualify if…
You will visit the study site on two separate days. On each day, you'll drink either the ketone supplement or a placebo drink that tastes similar but contains no active ingredient. The researchers will then measure how your body responds by testing your blood sugar control, checking your blood vessel function, measuring your blood pressure, and monitoring your heart response to exercise.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Canada
McGill University
Enrollment target
~60 participants
Started
January 2025
Primary completion
June 2027
Age range
18 Years – 40 Years
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Charlotte Usselman, Ph.D
McGill University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.